Видео ютуба по тегу Eli-Lilly

Eli Lilly CFO on $1 Billion AI Drug Lab Investment
Eli Lilly CFO on $1 Billion AI Drug Lab Investment
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
LILIT HOVHANNISYAN - ELI LILIT
LILIT HOVHANNISYAN - ELI LILIT
Eli Lilly reaches $1 trillion market value | REUTERS
Eli Lilly reaches $1 trillion market value | REUTERS
My Focus
My Focus
Eli Lilly's oral obesity treatment efficacy falls short of expectations, says BMO's Evan Seigerman
Eli Lilly's oral obesity treatment efficacy falls short of expectations, says BMO's Evan Seigerman
Nvidia Partners With Eli Lilly on AI Drug Laboratory
Nvidia Partners With Eli Lilly on AI Drug Laboratory
Внутри золотой лихорадки GLP-1: генеральный директор Eli Lilly о новых открытиях, зависимости и п...
Внутри золотой лихорадки GLP-1: генеральный директор Eli Lilly о новых открытиях, зависимости и п...
Hands | Lilly, A Medicine Company
Hands | Lilly, A Medicine Company
Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly
Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly
Eli Lilly in negotiations with Trump administration for the next pharma deal
Eli Lilly in negotiations with Trump administration for the next pharma deal
Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
Why Lilly?
Why Lilly?
Eli Lilly CEO talks deal to cut medication prices with the Trump administration
Eli Lilly CEO talks deal to cut medication prices with the Trump administration
Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine
Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock | LLY Stock | NVO Stock
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock | LLY Stock | NVO Stock
Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro
Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro
Дэвид А. Рикс, председатель и генеральный директор Eli Lilly and Company
Дэвид А. Рикс, председатель и генеральный директор Eli Lilly and Company
Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman
Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman
Eli Lilly lowers cost of Zepbound
Eli Lilly lowers cost of Zepbound